Protagenic Therapeutics, Inc. (PTIX) |
|
1.95 0.27 (16.07%)
|
03-24 15:57 |
|
Open: |
1.74 |
Pre. Close: |
1.68 |
|
High:
|
2.29 |
Low:
|
1.66 |
|
Volume:
|
107,747 |
Market Cap:
|
8(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:29:02 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 2.67  One year: 3.12 |
| Support: |
Support1: 1.06 Support2: 0.31 |
| Resistance: |
Resistance1: 2.28 Resistance2: 2.67 |
| Pivot: |
0.58 |
| Moving Average: |
MA(5): 0.97 MA(20): 0.54
MA(100): 0.51 MA(250): 0.63 |
| MACD: |
MACD(12,26): 0.1 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 82 %D(3): 63 |
| RSI: |
RSI(14): 93.4 |
| 52-week: |
High: 2.28 Low: 0.31 |
| Average Vol(K): |
3-Month: 28 (K) 10-Days: 55 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PTIX ] has closed above the upper band by 18.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 1080.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.29 - 2.3 |
2.3 - 2.31 |
|
Low:
|
1.64 - 1.65 |
1.65 - 1.66 |
|
Close:
|
1.94 - 1.95 |
1.95 - 1.96 |
|
Company Description |
|
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York. |
Headline News |
Fri, 24 Mar 2023
Healthcare Stocks Moving Friday: ECOR, RBOT, PTIX, PROK, CDTX, YS, NCNA, EAR - InvestorsObserver
Thu, 23 Mar 2023
Why Block Shares Are Trading Lower By Over 13%? Here Are Other ... - Investing.com UK
Wed, 22 Mar 2023
PROTAGENIC THERAPEUTICS, INC.NEW : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
Wed, 22 Mar 2023
Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split - Digital Journal
Mon, 17 Oct 2022
The 1001 Imploded Stocks of 2022 (Down 80% or More)… So Far - WOLF STREET
Mon, 10 May 2021
Market Update: The 10 Most Volatile Stocks Today - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
17 (M) |
| Shares Float |
13 (M) |
|
% Held by Insiders
|
21.2 (%) |
|
% Held by Institutions
|
9 (%) |
|
Shares Short
|
4 (K) |
|
Shares Short P.Month
|
1 (K) |
Stock Financials |
|
EPS
|
-0.25 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.11 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
-23.7 |
|
Return on Equity (ttm)
|
-43.4 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
0 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-2 (M) |
|
Levered Free Cash Flow
|
-1 (M) |
Stock Valuations |
|
PE Ratio
|
-7.9 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-17.73 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-15.19 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2016-07-26 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
